4//SEC Filing
AETHLON MEDICAL INC 4
Accession 0001683168-17-001075
$AEMDCIK 0000882291operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 12:02 PM ET
Size
7.9 KB
Accession
0001683168-17-001075
Insider Transaction Report
Form 4
Joyce James A
DirectorChair., Pres., CEO, CFO, Sec.10% Owner
Transactions
- Disposition to Issuer
Restricted Stock Units
2017-05-01−19,079→ 516,814 total→ Common Stock (19,079 underlying) - Exercise/Conversion
Common Stock
2017-05-01$2.23/sh+19,079$42,546→ 117,096 total
Footnotes (3)
- [F1]In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016.
- [F3]158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17 Represents conversion of restricted stock units with common stock issued on May 1, 2017 (with an effective date of April 28, 2017).
Documents
Issuer
AETHLON MEDICAL INC
CIK 0000882291
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000882291
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 12:02 PM ET
- Size
- 7.9 KB